Thus, GFRAL-triggered signaling cannot explain all of GDF15-mediated effects reported by us and others in the context of lung fibrosis (23, 34), cancer progression (69, 70), or cardiac disease (65), as was also recently reviewed by Wischhusen et al. (71). This evidence concerns the gene GFRAL and pulmonary fibrosis.